Skip to main content
. 2021 Sep 21;12:5552. doi: 10.1038/s41467-021-25847-2

Fig. 1. Workflow of this study.

Fig. 1

First, we develop HNPs with PEG modification to optimize their histone affinity, capacity, low-aggregation, and blood circulation time altogether to achieve highly effective sepsis therapy. Next, we evaluate PEGHNPs in vitro. Finally, we evaluate the efficacy of PEGHNPs using living mice in vivo.